Like other symptoms, itchy skin and rashes may not appear in the early stages of kidney disease. Instead, they may appear when the minerals in the blood become unbalanced due to the kidney’s ...

Acitretin: This medication is an oral (take by mouth) retinoid that can clear or markedly reduce widespread rashes, bumps, and other signs on your skin. Retinoids should not be used during pregnancy, ...

These rashes may develop due to changes in hormone levels, the rapid stretching of the skin, and underlying atopic (allergy-related) conditions. Some of these rashes can occur whether you are pregnant ...

A series where we find out which products the professionals (who really know what they’re talking about) actually use and really stand behind. Read more here. Building a skin-care routine for ...

Sanofi’s cancer immunotherapy Libtayo (cemiplimab) has a third US indication after the FDA approved it for certain untreated lung cancer patients. The approval in first-line lung cancer ...

Fortnite is packed with wondrous cosmetics that you can collect to customize your personal avatar. Though most outfits are created originally by Epic Games, recent years have introduced crossover ...

If you've ever seen your skin turn colors after too much time spent next to a heating pad, space heater, or other heating element, you may have experienced a condition known as toasted skin syndrome.

Sanofi and Regeneron’s checkpoint inhibitor Libtayo has become the first immunotherapy to improve survival when used as a second-line therapy in cervical cancer, setting up regulatory filings ...

Shaving with a razor is a quick, cheap and efficient way of banishing unwanted hair, but it occasionally comes with an unwanted side effect: shaving rash, or as it's more commonly known razor burn.

It's officially that time of the year: our skin is itchy, scaly, and more closely resembles a lizard than a dewy, glazed donut. You likely have a dozen barrier-repairing lip balms and thick hand ...

Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab) led to a statistically ...